company background image
6547 logo

Medigen Vaccine Biologics TPEX:6547 Stock Report

Last Price

NT$51.60

Market Cap

NT$17.0b

7D

1.8%

1Y

-1.0%

Updated

01 Jun, 2025

Data

Company Financials +

Medigen Vaccine Biologics Corporation

TPEX:6547 Stock Report

Market Cap: NT$17.0b

6547 Stock Overview

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan. More details

6547 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 41.3% below our estimate of its fair value

Risk Analysis

Earnings have declined by 10.1% per year over past 5 years

Volatile share price over the past 3 months compared to the TW market


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Medigen Vaccine Biologics Corporation Competitors

Price History & Performance

Summary of share price highs, lows and changes for Medigen Vaccine Biologics
Historical stock prices
Current Share PriceNT$51.60
52 Week HighNT$57.00
52 Week LowNT$33.70
Beta1.05
1 Month Change-4.62%
3 Month Change4.35%
1 Year Change-0.96%
3 Year Change-65.06%
5 Year Change-16.29%
Change since IPO142.90%

Recent News & Updates

Recent updates

We're Hopeful That Medigen Vaccine Biologics (GTSM:6547) Will Use Its Cash Wisely

Mar 31
We're Hopeful That Medigen Vaccine Biologics (GTSM:6547) Will Use Its Cash Wisely

Would Medigen Vaccine Biologics (GTSM:6547) Be Better Off With Less Debt?

Dec 15
Would Medigen Vaccine Biologics (GTSM:6547) Be Better Off With Less Debt?

Shareholder Returns

6547TW BiotechsTW Market
7D1.8%-0.4%-1.3%
1Y-1.0%-7.2%-0.5%

Return vs Industry: 6547 exceeded the TW Biotechs industry which returned -7.2% over the past year.

Return vs Market: 6547 matched the TW Market which returned -0.5% over the past year.

Price Volatility

Is 6547's price volatile compared to industry and market?
6547 volatility
6547 Average Weekly Movement8.9%
Biotechs Industry Average Movement8.0%
Market Average Movement7.4%
10% most volatile stocks in TW Market10.1%
10% least volatile stocks in TW Market4.9%

Stable Share Price: 6547's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: 6547's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
2012n/aLeo Leewww.medigenvac.com

Medigen Vaccine Biologics Corporation, a biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan. It develops enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection with severe complications; and Quadrivalent influenza vaccine, which is in Phase III clinical trial for the treatment of influenza viruses. The company also develops dengue vaccines, which has completed Phase II clinical trial to treat dengue; anti respiratory syncytial virus (RSV), which is in Phase I clinical trial for the prevention of RSV infection; and COVID-19 vaccine, which is in Phase III clinical trial to prevent COVID-19.

Medigen Vaccine Biologics Corporation Fundamentals Summary

How do Medigen Vaccine Biologics's earnings and revenue compare to its market cap?
6547 fundamental statistics
Market capNT$16.96b
Earnings (TTM)-NT$28.09m
Revenue (TTM)NT$662.47m
25.6x
P/S Ratio
-603.8x
P/E Ratio

Is 6547 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6547 income statement (TTM)
RevenueNT$662.47m
Cost of RevenueNT$235.88m
Gross ProfitNT$426.58m
Other ExpensesNT$454.67m
Earnings-NT$28.09m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.085
Gross Margin64.39%
Net Profit Margin-4.24%
Debt/Equity Ratio0.6%

How did 6547 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/01 13:32
End of Day Share Price 2025/05/29 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medigen Vaccine Biologics Corporation is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hsuan ChenKGI Securities Co. Ltd.
Yijun ChenSinoPac Securities Investment Service